Literature DB >> 2478327

Antigenic analysis of the second extra-cellular loop of the human beta-adrenergic receptors.

Y Magnusson1, S Höyer, R Lengagne, M P Chapot, J G Guillet, A Hjalmarson, A D Strosberg, J Hoebeke.   

Abstract

Polyclonal antibodies were raised in rabbits by immunization with free peptides corresponding to positions 197-222 of the human beta 1-adrenergic receptor (beta 1 peptide) and the corresponding sequence (172-197) of the human beta 2-adrenergic receptor (beta 2 peptide). While the beta 2 peptide yielded antibodies that cross-reacted with the beta 1 peptide, the antibodies against the beta 1 peptide did not cross-react with the beta 2 sequence. Cross-reactivity of the anti-beta 2 peptide antibodies and the selectivity of the anti-beta 1 peptide antibodies were also revealed in the recognition by immunoblots of the beta 1- and beta 2-adrenergic receptors of different species or of the receptor gene products expressed in a bacterial vector. These antibodies could be used immunohistochemically to visualize the beta-adrenergic receptors on rabbit heart. The anti-beta 2 peptide antibodies did not show any functional effect on the beta-adrenergic receptors; the anti-beta 1 peptide antibodies were able to displace agonist affinity to higher values. Recognition of truncated peptides by the anti-beta 1 and anti-beta 2 peptide antibodies suggested that the cross-reaction of the anti-beta 2 peptide antibodies was due to the recognition of a common epitope on the C-terminal part of the peptides. The anti-beta 1 peptide antibodies recognized the N-terminal part of the peptide better than the C-terminal part. These results suggest that the second extracellular loop postulated in the structure of the human beta-adrenergic receptor contains the T and B cell epitopes necessary for induction of an immune response. The selectivity and the functional properties of the antibodies raised against that loop in the beta 1 adrenergic receptor could have relevance in induction of auto antibodies in certain cardiomyopathic conditions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478327      PMCID: PMC1534593     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors.

Authors:  R R Almon; C G Andrew; S H Appel
Journal:  Science       Date:  1974-10-04       Impact factor: 47.728

2.  Presence of both beta1- and beta2-adrenergic receptors in a single cell type.

Authors:  V Homburger; M Lucas; E Rosenbaum; G Vassent; J Bockaert
Journal:  Mol Pharmacol       Date:  1981-11       Impact factor: 4.436

3.  Antibody-induced desensitization of the insulin receptor. Studies of the mechanism of desensitization in 3T3-L1 fatty fibroblasts.

Authors:  C Grunfeld; E Van Obberghen; F A Karlsson; C R Kahn
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

4.  Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy.

Authors:  C J Limas; I F Goldenberg; C Limas
Journal:  Circ Res       Date:  1989-01       Impact factor: 17.367

5.  A circulating IgG in Chagas' disease which binds to beta-adrenoceptors of myocardium and modulates their activity.

Authors:  E Borda; J Pascual; P Cossio; M De La Vega; R Arana; L Sterin-Borda
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

6.  Corticosteroid modulation of muscarinic receptors in rat myocardial membranes.

Authors:  B A Jacobsson; C H Bergh; A Hjalmarson
Journal:  Biochim Biophys Acta       Date:  1983-10-04

7.  The human carcinoma cell line A431 possesses large numbers of functional beta-adrenergic receptors.

Authors:  C Delavier-Klutchko; J Hoebeke; A D Strosberg
Journal:  FEBS Lett       Date:  1984-04-24       Impact factor: 4.124

8.  Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits.

Authors:  S J Tzartos; J M Lindstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

9.  Autoantibodies to beta 2-adrenergic receptors: a possible cause of adrenergic hyporesponsiveness in allergic rhinitis and asthma.

Authors:  J C Venter; C M Fraser; L C Harrison
Journal:  Science       Date:  1980-03-21       Impact factor: 47.728

10.  The cardiac beta-adrenergic receptor. Structural similarities of beta 1 and beta 2 receptor subtypes demonstrated by photoaffinity labeling.

Authors:  G L Stiles; R H Strasser; T N Lavin; L R Jones; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1983-07-10       Impact factor: 5.157

View more
  14 in total

1.  Induction of a pharmacologically active clonotypic B cell response directed to an immunogenic region of the human beta 2-adrenergic receptor.

Authors:  J G Guillet; R Lengagne; Y Magnusson; K Tate; A D Strosberg; J Hoebeke
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

Review 2.  Biotechnology of beta-adrenergic receptors.

Authors:  A D Strosberg
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

3.  Characterization of anti-peptide antibodies directed against an extracellular immunogenic epitope on the human alpha 1-adrenergic receptor.

Authors:  M L Fu; G Wallukat; A Hjalmarson; J Hoebeke
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

4.  Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus.

Authors:  D Kaplan; I Ferrari; P L Bergami; E Mahler; G Levitus; P Chiale; J Hoebeke; M H Van Regenmortel; M J Levin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

5.  The beta1 adrenergic effects of antibodies against the C-terminal end of the ribosomal P2beta protein of Trypanosoma cruzi associate with a specific pattern of epitope recognition.

Authors:  P Lopez Bergami; K A Gómez; G V Levy; V Grippo; A Baldi; M J Levin
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

6.  Cellular signaling by an agonist-activated receptor/Gs alpha fusion protein.

Authors:  B Bertin; M Freissmuth; R Jockers; A D Strosberg; S Marullo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

7.  Immunological Evidence of Thaumatin-Like Proteins during Tobacco Floral Differentiation.

Authors:  L Richard; M Arró; J Hoebeke; D R Meeks-Wagner; K T Van
Journal:  Plant Physiol       Date:  1992-01       Impact factor: 8.340

8.  Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy.

Authors:  Y Magnusson; S Marullo; S Hoyer; F Waagstein; B Andersson; A Vahlne; J G Guillet; A D Strosberg; A Hjalmarson; J Hoebeke
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

9.  Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy.

Authors:  Roland Jahns; Valérie Boivin; Lutz Hein; Sven Triebel; Christiane E Angermann; Georg Ertl; Martin J Lohse
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

10.  Animal models of cardiac disease and stem cell therapy.

Authors:  Lailiang Ou; Wenzhong Li; Yi Liu; Yue Zhang; Shen Jie; Deling Kong; Gustav Steinhoff; Nan Ma
Journal:  Open Cardiovasc Med J       Date:  2010-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.